O4, Jared Holz of Mizuho joined ‘Power Lunch’ on CNBC to talk about how to play biotech moving into 2026. Holz noted that ...

Looking for top-rated stocks to buy now? Recent analyst updates highlight three biotech companies that have earned Strong Buy ratings from ...

With this in mind, let's check out my top five stocks to buy in early 2026. Four have proven their earnings strength over ...

Biotech's 2025 rebound sets the stage for Denali Therapeutics and two peers, with key FDA decisions and pipeline catalysts ...

Beaten-down biotech stocks like ALT, IBRX and MCRB are eyeing a 2026 rebound as FDA alignment, pipeline progress and approvals fuel optimism.

BioNTech SE (NASDAQ:BNTX) is one of the best biotech stocks to buy according to Wall Street analysts. On December 8, Clear Street analysts reiterated a Buy rating on BioNTech SE (NASDAQ:BNTX), buoyed ...

After a sluggish first half, the drug and biotech sector has staged a recovery over the past two to three months. This ...

Solid Biosciences, valued at $463 million, will have updated Phase I/II Duchenne muscular dystrophy data in 2026, along with three FDA meetings in the first half of the year to finalize Phase III ...

This stock is a great choice for cautious and aggressive investors.

Antique said it expected Concord Biotech to deliver revenue, Ebitda and PAT CAGR of 18 per cent, 17 per cent and 19 per cent, ...